Here's the live share price of Orchid Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Orchid Pharma | -3.43 | 7.25 | -22.45 | -24.50 | -32.34 | 12.79 | -18.73 |
| Sun Pharmaceutical Industries | -2.11 | -5.44 | 1.62 | -1.67 | -4.95 | 19.26 | 21.00 |
| Divi's Laboratories | 1.86 | 4.65 | 3.61 | -4.11 | 6.35 | 25.33 | 10.86 |
| Torrent Pharmaceuticals | -1.54 | -2.89 | 1.69 | 13.12 | 26.09 | 36.15 | 26.00 |
| Lupin | -1.10 | 0.71 | 6.85 | 19.25 | 13.02 | 48.81 | 16.86 |
| Dr. Reddy's Laboratories | 0.18 | -2.56 | 0.27 | -4.64 | 3.88 | 8.29 | 3.25 |
| Cipla | 0.37 | 0.69 | -10.24 | -25.17 | -19.43 | 10.89 | 5.45 |
| Zydus Lifesciences | -0.57 | 8.15 | 5.18 | -7.65 | 9.17 | 21.63 | 11.00 |
| Mankind Pharma | 4.87 | 15.79 | 3.64 | -9.12 | -13.57 | 16.02 | 9.33 |
| Aurobindo Pharma | 2.36 | 10.06 | 22.90 | 28.12 | 18.50 | 33.66 | 7.23 |
| Alkem Laboratories | 1.93 | 10.46 | -1.41 | 2.78 | 13.39 | 18.32 | 15.23 |
| Glenmark Pharmaceuticals | -2.17 | 5.93 | 10.78 | 19.53 | 59.06 | 62.35 | 31.26 |
| Laurus Labs | 0.02 | 16.19 | 11.17 | 19.26 | 71.44 | 55.32 | 19.77 |
| Biocon | 2.15 | -2.55 | -3.93 | -1.20 | 7.20 | 16.65 | -2.17 |
| Abbott India | -1.89 | 0.03 | -8.01 | -15.35 | -17.77 | 4.19 | 11.04 |
| Anthem Biosciences | 3.15 | 19.66 | 23.82 | 4.71 | 2.98 | 0.99 | 0.59 |
| GlaxoSmithKline Pharmaceuticals | 0.82 | 6.41 | 1.94 | -12.09 | -13.62 | 24.62 | 10.73 |
| Ipca Laboratories | 1.75 | -2.32 | 0.79 | 17.55 | 3.68 | 21.95 | 7.34 |
| Ajanta Pharma | -4.11 | -1.10 | 1.93 | 14.62 | 3.19 | 29.17 | 17.83 |
| J B Chemicals & Pharmaceuticals | -0.07 | -5.10 | 3.99 | 15.80 | 19.40 | 23.66 | 24.21 |
Over the last one year, Orchid Pharma has declined 32.34% compared to peers like Sun Pharmaceutical Industries (-4.95%), Divi's Laboratories (6.35%), Torrent Pharmaceuticals (26.09%). From a 5 year perspective, Orchid Pharma has underperformed peers relative to Sun Pharmaceutical Industries (21.00%) and Divi's Laboratories (10.86%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 558.93 | 555.95 |
| 10 | 548.37 | 549.06 |
| 20 | 532.45 | 545.77 |
| 50 | 583.63 | 583.57 |
| 100 | 681.86 | 641.79 |
| 200 | 714.05 | 723.88 |
In the latest quarter, Orchid Pharma remained same as its previous close in promoter holding, while DII stake increased to 20.24%, FII holding fell to 0.87%, and public shareholding moved down to 9.04% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 34,65,947 | 0.65 | 167.21 | |
| 13,75,000 | 0.77 | 66.34 | |
| 9,90,763 | 0.27 | 47.8 | |
| 9,42,962 | 0.38 | 45.49 | |
| 4,55,183 | 0.24 | 21.96 | |
| 4,36,553 | 0.1 | 21.06 | |
| 4,27,811 | 1.67 | 20.64 | |
| 2,83,362 | 0.33 | 13.67 | |
| 2,66,000 | 0.84 | 12.83 | |
| 2,64,308 | 0.06 | 12.75 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Apr 11, 2026, 11:08 PM IST IST | Orchid Pharma - Intimation Under Regulation 30 |
| Apr 09, 2026, 05:48 AM IST IST | Orchid Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Apr 07, 2026, 11:49 PM IST IST | Orchid Pharma - Investor Roadshow Scheduled To Be Held On April 10, 2026. |
| Apr 02, 2026, 09:21 PM IST IST | Orchid Pharma - Announcement under Regulation 30 (LODR)-Credit Rating |
| Mar 19, 2026, 02:47 AM IST IST | Orchid Pharma - Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited (''Amalgamating Company'') With |
Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 921.93 Cr. and Equity Capital is Rs. 50.72 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Orchid Pharma is ₹546.80 as on Apr 22, 2026.
The Orchid Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Orchid Pharma is ₹2,779.66 Cr as on Apr 22, 2026.
Today’s highest and lowest price of Orchid Pharma are ₹558.85 and ₹534.95.
The 52-week high/low is the highest and lowest price at which Orchid Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Orchid Pharma is ₹898.45 and 52-week low of Orchid Pharma is ₹471.30 as on Apr 22, 2026.
The Orchid Pharma has shown returns of -1.49% over the past day, 7.01% for the past month, -22.63% over 3 months, -32.49% over 1 year, 12.7% across 3 years, and -18.77% over 5 years.
P/E ratio of and PB ratio of Orchid Pharma are 147.33 and 2.20 on Apr 22, 2026. While the company gives a dividend yield of 0.00 per annum.